GlassScriptPhysician profile
Marina Fest
NPI 1285020842
$6,508.77
in general payments reported to CMS, 2019-2025
32 companies · $2,207 in 2025
The $2,207 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $778 · 2022: $969 · 2023: $1,179 · 2024: $1,376 · 2025: $2,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,700 · Education: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,700.14 |
| Education | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,463.64 | 2021-2025 | |
| Pfizer INC. | $492.43 | 2023-2025 | |
| Glaxosmithkline, LLC. | $433.01 | 2021-2024 | Trelegy Ellipta |
| Intra-Sana Laboratories | $342.27 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Lilly USA, LLC | $334.37 | 2023-2025 | Mounjaro, Trulicity, Zepbound |
| Astrazeneca Pharmaceuticals LP | $289.36 | 2024-2025 | Breztri, Airsupra |
| Antares Pharma, INC. | $271.27 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $268.31 | 2022-2025 | Xifaxan |
| Scilex Pharmaceuticals INC. | $250.04 | 2024-2025 | |
| Astellas Pharma US INC | $228.75 | 2023-2025 | Veozah |
| Ardelyx, INC. | $221.90 | 2024-2025 | Ibsrela |
| Kowa Pharmaceuticals America, INC. | $145.82 | 2025 | Zoryve |
| Axsome Therapeutics, INC. | $139.00 | 2025 | Symbravo |
| Almatica Pharma LLC | $95.42 | 2025 | Loreev Xr |
| Corcept Therapeutics | $69.52 | 2025 | Korlym |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $62.77 | 2025 | Neffy |
| Biohaven Pharmaceutical Holding Company LTD. | $55.78 | 2022 | |
| Scynexis, INC. | $41.32 | 2022 | |
| Organon LLC | $40.57 | 2021-2022 | |
| Exact Sciences Corporation | $36.90 | 2023 | Cologuard Collection Kit |
| Novo Nordisk INC | $23.35 | 2024 | Wegovy |
| Tonix Medicines, INC. | $22.87 | 2025 | Zembrace Symtouch |
| Shield Therapeutics INC | $22.24 | 2025 | |
| Amarin Pharma, INC. | $21.42 | 2021 | |
| Halozyme INC | $19.96 | 2023 | |
| Ironwood Pharmaceuticals, INC | $19.05 | 2021 | |
| Nestle Healthcare Nutrition INC. | $17.88 | 2023 | |
| Genzyme Corporation | $17.76 | 2024 | |
| Horizon Therapeutics Plc | $17.37 | 2022 | |
| Metacel Pharmaceuticals LLC | $16.22 | 2023 | Ozobax |
| Agile Therapeutics, INC. | $16.20 | 2021 | |
| Impel Pharmaceuticals INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marina Fest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.